Brian Kirkpatrick
Professor
Also affiliated: University of Maryland, Baltimore (1989–2006); University of Georgia (2023); Central Washington University (1976–1978); University of Minnesota, Duluth (2011); Texas Instruments (United States) (2003–2020)
Faculty Researcher
Psychiatry, College of Medicine
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Brian Kirkpatrick's research centers on the study of schizophrenia, with a particular focus on negative symptoms and their clinical implications. He has published on the description and treatment of negative symptoms, contributing to a new understanding of this aspect of the disorder. His work also explores related issues such as motivation, sedation effects of medication, and the impact of glucose dysregulation in first-episode psychosis.
Kirkpatrick's scholarship includes 20 publications with 1,199 citations and an h-index of 11. He has collaborated with researchers such as Lauren Luther from the University of Arkansas at Fayetteville, with whom he has co-authored shared publications. His recent activity and publications indicate an ongoing engagement with the field of psychiatric research.
Metrics
- h-index: 11
- Publications: 20
- Citations: 1,208
Selected Publications
-
Subjective perceptions of negative symptoms among outpatients with schizophrenia and their relatives or caregivers: Definitions, importance, measurement, and desired improvement (2026)
-
Schizophrenia and accelerated ageing: systematic review and future research directions (2026)
-
No conflict of interest, Fetal Programmingand inclusive and glucosedysregulation in first-episode psychosis (2023)
-
Negative symptoms in the clinic: we treat what we can describe (2023)
-
A new era for the negative symptoms of schizophrenia (2023)
Grants & Funding
As listed on this researcher's institutional profile.
- Developing First Episode of Psychosis Specialty Treatment Services for Arkansas. Substance Abuse & Mental Health Services Administration via Arkansas Department of Human Services Principal Investigator
- First Episode Psychosis (FEP) Phase 4 Substance Abuse & Mental Health Services Administration via Arkansas Department of Human Services Principal Investigator
Collaboration Network
Top Collaborators
- A new era for the negative symptoms of schizophrenia
- No conflict of interest, Fetal Programmingand inclusive and glucosedysregulation in first-episode psychosis
- Schizophrenia and accelerated ageing: systematic review and future research directions
- No conflict of interest, Fetal Programmingand inclusive and glucosedysregulation in first-episode psychosis
- Schizophrenia and accelerated ageing: systematic review and future research directions
- A new era for the negative symptoms of schizophrenia
- A new era for the negative symptoms of schizophrenia
- Negative symptoms in the clinic: we treat what we can describe
- Negative symptoms in the clinic: we treat what we can describe
- No conflict of interest, Fetal Programmingand inclusive and glucosedysregulation in first-episode psychosis
- No conflict of interest, Fetal Programmingand inclusive and glucosedysregulation in first-episode psychosis
- No conflict of interest, Fetal Programmingand inclusive and glucosedysregulation in first-episode psychosis
- No conflict of interest, Fetal Programmingand inclusive and glucosedysregulation in first-episode psychosis
Similar Researchers
Based on overlapping research topics